Due to the systemic prevalence of VEGF, anti-VEGF drugs are currently used to treat different types of cancers (especially renal cancer), wet age-related macular degeneration, and macular edema, as well as diabetic retinopathy [32,33,34,35,36]. This evidence concerns the gene VEGFA and cancer.